ReP USP - Resultado da busca

Artigo de periodico
Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer (2023)
Fukumori, Claudio ; Branco, Paola Cristina ; Barreto, Thayná ; Ishida, Kelly ; Lopes, Luciana Biagini
Source: European Journal of Pharmaceutical Sciences. Unidade: ICB
Subjects: FARMACOLOGIA, MICROBIOLOGIA, NEOPLASIAS COLORRETAIS, ANTINEOPLÁSICOS, QUIMIOTERAPIA, CITOTOXINAS, GORDURAS, ALGINATOS, MUTAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUKUMORI, Claudio et al. Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer. European Journal of Pharmaceutical Sciences, v. 187, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2023.106465. Acesso em: 09 nov. 2024.
APA
Fukumori, C., Branco, P. C., Barreto, T., Ishida, K., & Lopes, L. B. (2023). Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer. European Journal of Pharmaceutical Sciences, 187, 1-15. doi:10.1016/j.ejps.2023.106465
NLM
Fukumori C, Branco PC, Barreto T, Ishida K, Lopes LB. Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 187 1-15.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2023.106465
Vancouver
Fukumori C, Branco PC, Barreto T, Ishida K, Lopes LB. Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 187 1-15.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2023.106465
Artigo de periodico
Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation (2020)
Horoiwa, Thais Aragão ; Cortez, Mauro ; Sauter, Ismael Pretto ; Migotto, Amanda; Bandeira, Carla Letícia ; Cerize, Natália Neto Pereira ; Oliveira, Adriano Marim de
Source: European Journal of Pharmaceutical Sciences. Unidade: ICB
Subjects: PARASITOLOGIA, LEISHMANIOSE CUTÂNEA, ANTIMÔNIO, NANOPARTÍCULAS, INFECÇÕES POR PROTOZOÁRIOS, DOENÇAS PARASITÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOROIWA, Thais Aragão et al. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation. European Journal of Pharmaceutical Sciences, v. 147, p. 9 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105295. Acesso em: 09 nov. 2024.
APA
Horoiwa, T. A., Cortez, M., Sauter, I. P., Migotto, A., Bandeira, C. L., Cerize, N. N. P., & Oliveira, A. M. de. (2020). Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation. European Journal of Pharmaceutical Sciences, 147, 9 . doi:10.1016/j.ejps.2020.105295
NLM
Horoiwa TA, Cortez M, Sauter IP, Migotto A, Bandeira CL, Cerize NNP, Oliveira AM de. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 147 9 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2020.105295
Vancouver
Horoiwa TA, Cortez M, Sauter IP, Migotto A, Bandeira CL, Cerize NNP, Oliveira AM de. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 147 9 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2020.105295
Artigo de periodico
Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole (2020)
Passos, Julia Sapienza ; Martino, Luiza Capello de; Dartora, Vanessa Franco Carvalho; Araujo, Gabriel Lima Barros de ; Ishida, Kelly ; Lopes, Luciana Biagini
Source: European Journal of Pharmaceutical Sciences. Unidades: FCF, ICB
Subjects: MICROBIOLOGIA, FARMACOLOGIA, NANOPARTÍCULAS, ANTIFÚNGICOS, PELE, ESPOROTRICOSE, DERMATOPATIAS INFECCIOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASSOS, Julia Sapienza et al. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole. European Journal of Pharmaceutical Sciences, v. 149, p. 11 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105296. Acesso em: 09 nov. 2024.
APA
Passos, J. S., Martino, L. C. de, Dartora, V. F. C., Araujo, G. L. B. de, Ishida, K., & Lopes, L. B. (2020). Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole. European Journal of Pharmaceutical Sciences, 149, 11 . doi:10.1016/j.ejps.2020.105296
NLM
Passos JS, Martino LC de, Dartora VFC, Araujo GLB de, Ishida K, Lopes LB. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 149 11 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2020.105296
Vancouver
Passos JS, Martino LC de, Dartora VFC, Araujo GLB de, Ishida K, Lopes LB. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 149 11 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2020.105296
Artigo de periodico
Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models (2017)
Carvalho, Vanessa F. M; Migotto, Amanda; Giacone, Daniela V; Lemos, Débora P. de; Zanoni, Thalita B; Maria-Engler, Silvya Stuchi ; Costa-Lotufo, Letícia Veras ; Lopes, Luciana Biagini
Source: European Journal of Pharmaceutical Sciences. Unidades: FCF, ICB
Subjects: PELE, MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Vanessa F. M et al. Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models. European Journal of Pharmaceutical Sciences, v. 109, p. 131-143, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2017.07.023. Acesso em: 09 nov. 2024.
APA
Carvalho, V. F. M., Migotto, A., Giacone, D. V., Lemos, D. P. de, Zanoni, T. B., Maria-Engler, S. S., et al. (2017). Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models. European Journal of Pharmaceutical Sciences, 109, 131-143. doi:10.1016/j.ejps.2017.07.023
NLM
Carvalho VFM, Migotto A, Giacone DV, Lemos DP de, Zanoni TB, Maria-Engler SS, Costa-Lotufo LV, Lopes LB. Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109 131-143.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2017.07.023
Vancouver
Carvalho VFM, Migotto A, Giacone DV, Lemos DP de, Zanoni TB, Maria-Engler SS, Costa-Lotufo LV, Lopes LB. Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109 131-143.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2017.07.023
Artigo de periodico
Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells (2016)
Rodrigues, Alice Cristina ; Neri, Elida Adalgisa; Veríssimo Filho, Sidney; Rebouças, Nancy Amaral; Hirata, Rosario Dominguez Crespo ; Yu, Ai Ming
Source: European Journal of Pharmaceutical Sciences. Unidades: ICB, FCF
Subjects: HIPERCOLESTEROLEMIA, EXPRESSÃO GÊNICA, RNA MENSAGEIRO, FISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina et al. Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells. European Journal of Pharmaceutical Sciences, v. 93, p. 431-436, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2016.08.044. Acesso em: 09 nov. 2024.
APA
Rodrigues, A. C., Neri, E. A., Veríssimo Filho, S., Rebouças, N. A., Hirata, R. D. C., & Yu, A. M. (2016). Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells. European Journal of Pharmaceutical Sciences, 93, 431-436. doi:10.1016/j.ejps.2016.08.044
NLM
Rodrigues AC, Neri EA, Veríssimo Filho S, Rebouças NA, Hirata RDC, Yu AM. Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2016 ; 93 431-436.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2016.08.044
Vancouver
Rodrigues AC, Neri EA, Veríssimo Filho S, Rebouças NA, Hirata RDC, Yu AM. Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2016 ; 93 431-436.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2016.08.044
Artigo de periodico
Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells (2009)
Rodrigues, Alice Cristina ; Curi, Rui; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: European Journal of Pharmaceutical Sciences. Unidades: ICB, FCF
Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina et al. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, v. 37, n. 3-4, p. 486-491, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2009.04.006. Acesso em: 09 nov. 2024.
APA
Rodrigues, A. C., Curi, R., Hirata, M. H., & Hirata, R. D. C. (2009). Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, 37( 3-4), 486-491. doi:10.1016/j.ejps.2009.04.006
NLM
Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006
Vancouver
Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006
Trabalho de evento-anais periodico
Effect of organic extracts and flavanoids isolated from Lychonophora markgravii on viability of Leishmania amastigotes (2001)
Salvador, Marcos José; Pral, Elizabeth Mieko Furusho; Sartori, Fabiana Terezinha; Sacilotto, Ana Cláudia Barrachi Costa; Alfieri, Silvia Celina; Vichewski, W
Source: European Journal of Pharmaceutical Sciences. Conference titles: Congresso de Ciência Farmacêuticas (CIFARP). Unidades: ICB, FCFRP
Assunto: PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALVADOR, Marcos José et al. Effect of organic extracts and flavanoids isolated from Lychonophora markgravii on viability of Leishmania amastigotes. European Journal of Pharmaceutical Sciences. Amesterdã: Elsevier Science. . Acesso em: 09 nov. 2024. , 2001
APA
Salvador, M. J., Pral, E. M. F., Sartori, F. T., Sacilotto, A. C. B. C., Alfieri, S. C., & Vichewski, W. (2001). Effect of organic extracts and flavanoids isolated from Lychonophora markgravii on viability of Leishmania amastigotes. European Journal of Pharmaceutical Sciences. Amesterdã: Elsevier Science.
NLM
Salvador MJ, Pral EMF, Sartori FT, Sacilotto ACBC, Alfieri SC, Vichewski W. Effect of organic extracts and flavanoids isolated from Lychonophora markgravii on viability of Leishmania amastigotes. European Journal of Pharmaceutical Sciences. 2001 ;13 S96.[citado 2024 nov. 09 ]
Vancouver
Salvador MJ, Pral EMF, Sartori FT, Sacilotto ACBC, Alfieri SC, Vichewski W. Effect of organic extracts and flavanoids isolated from Lychonophora markgravii on viability of Leishmania amastigotes. European Journal of Pharmaceutical Sciences. 2001 ;13 S96.[citado 2024 nov. 09 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Funding Agencies

Indexado em

Non normalized affiliation